31. Lipodystrophy-like features after total body irradiation among survivors of childhood acute leukemia. S. Visentin et al. Endocrine connections. 2019 Apr;8(4):349-359.
30. Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population. C. Oudin et al. Haematologica. 2018 Apr;103(4):645-654.
28. Metabolic Syndrome Among Leukemia Survivors: Still Delineating the Risk. P. Saultier et al. Metab Syndr Relat Disord. 2017 Aug;15(6):263-265.
26. Late effects in survivors of infantile acute leukemia: a study of the L.E.A program. V. Gandemer et al. Blood Cancer J. 2017 Jan; 7(1): e518.
25. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study. P. Saultier et al. Haematologica. 2016 Dec;101(12):1603-1610.
22. Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study. C. Oudin et al. Haematologica. 2016 Jun;101(6):747-56.
21. Educational and occupational outcomes of childhood cancer survivors 30 years afterdiagnosis: a French cohort study. A. Dumas et al. Br J Cancer. 2016 Apr 26;114(9):1060-8.
20. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study. A. Sirvent et al. Bone Marrow Transplant. 2016 Jan;52(1):80-87.
19. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. C. Oudin et al. Bone Marrow Transplant. 2015 Nov;50(11):1438-44.
15. Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation. J. Benadiba et al. J Pediatr Hematol Oncol. 2015 Mar;37(2):109-16.
13. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study. M. Horwitz et al. Br J Haematol. 2015 Feb;168(4):518-25.
12. Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study. F. Bernard et al. Bone Marrow Transplant. 2014 May;49(5):709-16.
11. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study. AL. Alloin et al. Br J Haematol. 2014 Jan;164(1):94-100.
6. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-UpStudy (LEA). F. Isfan et al. Bone Marrow Transplant. 2012 May;47(5):684-93.
3. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. C. Oudin et al. Blood. 2011 Apr 28;117(17):4442-8.
2. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI. F. Bernard et al. Bone Marrow Transplant. 2009 Apr;43(8):637-42.